TBWA's win last week of $170 million of the GlaxoSmithKline Consumer Healthcare business comes with what a lot of agencies would consider an unpleasant side effect: the chore of marketing a weight-loss drug that can result in...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Alli and Its Side Effects Is Now TBWA's Marketing Problem - Agency News
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account